Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Skip to main content

Healthcare & Pharmaceuticals

India grants emergency approval for Moderna's COVID-19 vaccine - govt official

1 minute read

A vial and sryinge are seen in front of a displayed Moderna logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration

June 29 (Reuters) - India's Cipla Ltd (CIPL.NS) has been granted a new drug permission for restricted use of Moderna Inc's (MRNA.O) COVID-19 vaccine in the country, a senior government official said on Tuesday.

Reporting by Bhargav Acharya in Bengaluru; Editing by Louise Heavens

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters